L150-0360 Screening compound: N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-4-(5-{[(4-fluorophenyl)methyl]sulfanyl}-1H-1,2,3,4-tetrazol-1-yl)benzamide

L150-0360 Screening compound: N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-4-(5-{[(4-fluorophenyl)methyl]sulfanyl}-1H-1,2,3,4-tetrazol-1-yl)benzamide
L150-0360 Screening compound: N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-4-(5-{[(4-fluorophenyl)methyl]sulfanyl}-1H-1,2,3,4-tetrazol-1-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L150-0360
N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-4-(5-{[(4-fluorophenyl)methyl]sulfanyl}-1H-1,2,3,4-tetrazol-1-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L150-0360

Molecular Formula

C24H16F2N6OS2 (C24 H16 F2 N6 OS2)

Compound Name

N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-4-(5-{[(4-fluorophenyl)methyl]sulfanyl}-1H-1,2,3,4-tetrazol-1-yl)benzamide

IUPAC name

N-[4-(4-fluorophenyl)-13-thiazol-2-yl]-4-(5-{[(4-fluorophenyl)methyl]sulfanyl}-1H-1234-tetrazol-1-yl)benzamide

SMILES

O=C(c(cc1)ccc1-n1nnnc1SCc(cc1)ccc1F)Nc1nc(-c(cc2)ccc2F)cs1

InChI

InChI=1S/C24H16F2N6OS2/c25-18-7-1-15(2-8-18)13-35-24-29-30-31-32(24)20-11-5-17(6-12-20)22(33)28-23-27-21(14-34-23)16-3-9-19(26)10-4-16/h1-12,14H,13H2,(H,27,28,33)

InChI Key

FFVBCACPDAGAHP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15119357

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

506.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.726

Distribution Coefficient, logD

5.725

Water Solubility, LogSw

-5.87

Polar Surface Area

72.755

Acid Dissociation Constant (pKa)

10.04

Base Dissociation Constant (pKb)

-1.03

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

4.20

L150-0360 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L150-0360 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L150-0360?
Check Price and Availability of L150-0360, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L150-0360 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L150-0360
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L150-0360
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L150-0360 available by request